Praxis Precision Medicines (PRAX) Profit After Tax: 2022-2025
Historic Profit After Tax for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to -$73.9 million.
- Praxis Precision Medicines' Profit After Tax fell 42.43% to -$73.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$273.0 million, marking a year-over-year decrease of 80.80%. This contributed to the annual value of -$182.8 million for FY2024, which is 48.30% down from last year.
- Praxis Precision Medicines' Profit After Tax amounted to -$73.9 million in Q3 2025, which was down 3.95% from -$71.1 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Profit After Tax ranged from a high of -$24.6 million in Q3 2023 and a low of -$73.9 million during Q3 2025.
- In the last 3 years, Praxis Precision Medicines' Profit After Tax had a median value of -$39.6 million in 2024 and averaged -$47.3 million.
- As far as peak fluctuations go, Praxis Precision Medicines' Profit After Tax soared by 45.49% in 2023, and later plummeted by 118.32% in 2024.
- Praxis Precision Medicines' Profit After Tax (Quarterly) stood at -$41.2 million in 2022, then skyrocketed by 34.72% to -$26.9 million in 2023, then plummeted by 118.32% to -$58.7 million in 2024, then tumbled by 42.43% to -$73.9 million in 2025.
- Its Profit After Tax stands at -$73.9 million for Q3 2025, versus -$71.1 million for Q2 2025 and -$69.3 million for Q1 2025.